Guidelines for diagnosis and management of aphthous stomatitis

Pediatric Infectious Disease Journal

Volumn 26, Issue 8, 2007, Pages 728-732

  Femiano, Felice ^a,b   Lanza, Alessandro ^a   Buonaiuto, Curzio ^a   Gombos, Fernando ^a   Nunziata, Monica ^a   Piccolo, Silvia ^a   Cirillo, Nicola ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

Aphthae; Oral ulcer; RAS; Stomatitis

Indexed keywords

ANESTHETIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; CLOBETASOL; COLCHICINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DEXAMETHASONE; FLUOCINONIDE; PENTOXIFYLLINE; THALIDOMIDE; TRIAMCINOLONE;

APHTHOUS STOMATITIS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; HEALING; HUMAN; IMMUNOPATHOGENESIS; MEDICAL LITERATURE; MOUTH HYGIENE; PAIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REMISSION; REVIEW;

ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; HUMANS; STOMATITIS, APHTHOUS;

EID: 34548753527     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e31806215f9     Document Type: Review

References (54)

1. Ship JA. Recurrent aphthous stomatitis-an update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:141-147.
2. Shulman JD. Prevalence of oral mucosal lesions in children and youths in the USA. Int J Paediatr Dent. 2005;15:89-97.
3. Akintoye SO, Greenberg MS. Recurrent aphthous stomatitis. Dent Clin North Am. 2005;49:31-47.
4. Natah SS, Konttinen YT, Enattah NS, Ashammakhi N, Sharkey KA, Hayrinen-Immonen R. Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg. 2004;33:221-234.
5. Porter S, Scully C. Aphthous ulcers (recurrent). Clin Evid. 2005;13:1687-1694.
6. Scully C. Clinical practice. Aphthous ulceration. N Engl J Med. 2006;13:355:165-172.
7. Rioboo-Crespo Mdel R, Planells-del Pozo P, Rioboo-Garcia R. Epidemiology of the most common oral mucosal diseases in children. Med Oral Patol Oral Cir Bucal. 2005;10:376-387.
8. Pastore L, De Benedittis M, Petruzzi M, et al. Importance of oral signs in the diagnosis of atypical forms of celiac disease. Recenti Prog Med. 2004;95:482-490.
9. Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc. 2003;134:200-207.
10. Scully C. Mucosal diseases series. Oral Dis. 2005;11:57.
11. Shetty K. Thalidomide in the management of recurrent aphthous ulcerations in patients who are HIV-positive: a review and case reports. Spec Care Dentist. 2005;25:236-241.
12. Sciubba JJ. Herpes simplex and aphthous ulcerations: presentation, diagnosis and management - an update. Gen Dent. 2003;51:510-516.
13. Letsinger JA, McCarty MA, Jorizzo JL. Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide. J Am Acad Dermatol. 2005;52:500-508.
14. Rogers RS. Complex aphthosis. Adv Exp Med Biol. 2003;528:311-316.
15. McCarty MA, Garton RA, Jorizzo JL. Complex aphthosis and Behcet's disease. Dermatol Clin. 2003;21:41-48.
16. Coli P, Jontell M, Hakeberg M. The effect of a dentifrice in the prevention of recurrent aphthous stomatitis. Oral Health Prev Dent. 2004;2:133-141.
17. Boras VV, Lukac J, Brailo V, Picek P, Kordic D, Zilic IA. Salivary interleukin-6 and tumor necrosis factor-α in patients with recurrent aphthous ulceration. J Oral Pathol Med. 2006;35:241-243.
18. Volkov I, Rudoy I, Abu-Rabia U, Masalha T, Masalha R. Case report: recurrent aphthous stomatitis responds to vitamin B12 treatment. Can Fam Physician. 2005;51:844-845.
19. Sun A, Chang YF, Chia JS, Chiang CP. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of recurrent aphthous ulcerations. J Oral Pathol Med. 2004;33:133-139.
20. Aridogan BC, Yildirim M, Baysal V, Inaloz HS, Baz K, Kaya S. Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-γ in Behcet's disease. J Dermatol. 2003;30:602-607.
21. Jang HS, Jo JH, Kim BS, et al. A case of severe tongue ulceration and laryngeal inflammation induced by low-dose nicorandil therapy. Br J Dermatol. 2004;151:939-941.
22. Borra RC, Andrade PM, Silva ID, et al. The Th1/Th2 immune-type response of the recurrent aphthous ulceration analyzed by cDNA microarray. J Oral Pathol Med. 2004;33:140-146.
23. Ben Slama L. Aphthae and aphthosis. Rev Stomatol Chir Maxillofac. 2003;104:295-297.
24. Lewkowicz N, Lewkowicz P, Banasik M, Kurnatowska A, Tchorzewski H. Predominance of Type 1 cytokines and decreased number of CD4(+) CD25(+high) T regulatory cells in peripheral blood of patients with recurrent aphthous ulcerations. Immunol Lett. 2005;99:57-62.
25. Broides A, Yerushalmi B, Levy R, et al. Imerslund-Grasbeck syndrome associated with recurrent aphthous stomatitis and defective neutrophil function. J Pediatr Hematol Oncol. 2006;28:715-719.
26. Guimaraes AL, de Sa AR, Victoria JM, et al. Association of interleukin 1-β polymorphism with recurrent aphthous stomatitis in Brazilian individuals. Oral Dis. 2006;12:580-583.
27. Sun A, Wang JT, Chia JS, Chiang CP. Levamisole can modulate the serum tumor necrosis factor-α level in patients with recurrent aphthous ulcerations. J Oral Pathol Med. 2006;35:111-116.
28. Saulsbury FT, Wispelwey B. Tumor necrosis factor receptor-associated periodic syndrome in a young adult who had features of periodic fever, aphthous stomatitis, pharyngitis, and adenitis as a child. J Pediatr. 2005;146:283-285.
29. Bazrafshani MR, Hajeer AH, Ollier WE, Thornhill MH. Polymorphisms in the IL-10 and IL-12 gene cluster and risk of developing recurrent aphthous stomatitis. Oral Dis. 2003;9:287-291.
30. Arbiser JL, Johnson D, Cohen C, Brown LF. High-level expression of vascular endothelial growth factor and its receptors in an aphthous ulcer. J Cutan Med Surg. 2003;7:225-228.
31. Kalayciyan A, Orawa H, Fimmel S, et al. Nicotine and biochanin A, but not cigarette smoke, induce anti-inflammatory effects on keratinocytes and endothelial cells in patients with Behcet's disease. J Invest Dermatol. 2007;127:81-89.
32. Veller-Fornasa C, Bezze G, Rosin S, Lazzaro M, Tarantello M, Cipriani R. Recurrent aphthous stomatitis and atopy. Acta Derm Venereol. 2003;83:469-470.
33. Rhee SH, Kim YB, Lee ES. Comparison of Behcet's disease and recurrent aphthous ulcer according to characteristics of gastrointestinal symptoms. J Korean Med Sci. 2005;20:971-976.
34. Aydemir S, Tekin NS, Aktunc E, Numanoglu G, Ustundag Y. Celiac disease in patients having recurrent aphthous stomatitis. Turk J Gastroenterol. 2004;15:192-195.
35. Altinor S, Ozturkcan S, Hah MM. The effects of colchicine on neutrophil function in subjects with recurrent aphthous stomatitis. J Eur Acad Dermatol Venereol. 2003;17:469-470.
36. Boulinguez S, Sommet A, Bedane C, Viraben R, Bonnetblanc JM. Oral nicorandil-induced lesions are not aphthous ulcers. J Oral Pathol Med. 2003;32:482-485.
37. Lisi P, Hansel K, Assalve D. Aphthous stomatitis induced by piroxicam. J Am Acad Dermatol. 2004;50:648-649.
38. Madrid C. Aphthous ulcerations, an undesirable little-known effect of antihypertensive agents. Rev Med Suisse. 2005;1:2421.
39. Burgan SZ, Sawair FA, Amarin ZO. Hematologic status in patients with recurrent aphthous stomatitis in Jordan. Saudi Med J. 2006;27:381-384.
40. Bucci P, Carile F, Sangianantoni A, D'Angio F, Santarelli A, Muzio LL. Oral aphthous ulcers and dental enamel defects in children with coeliac disease. Acta Paediatr. 2006;95:203-207.
41. Thongprasom K, Youngnak P, Aneksuk V. Hematologic abnormalities in recurrent oral ulceration. Southeast Asian J Trop Med Public Health. 2002;33:872-877.
42. Leong SC, Karkos PD, Apostolidou MT. Is there a role for the otolaryngologist in PFAPA syndrome? A systematic review. Int J Pediatr Otorhinolaryngol. 2006;70:1841-1845.
43. Stojanov S, Hoffmann F, Kery A, et al. Cytokine profile in PFAPA syndrome suggests continuous inflammation and reduced anti-inflammatory response. Eur Cytokine Netw. 2006;17:90-97.
44. Frye RE. Recurrent aseptic encephalitis in periodic fever, aphthous stomatitis, pharyngitis and adenopathy (PFAPA) syndrome. Pediatr Infect Dis J. 2006;25:463-465.
45. Shetty K. Thalidomide for recurrent aphthous ulcerations. HIV Clin. 2003;15:1,4-6.
46. Esparza Gomez G. Management of aphtous stomatitis. Med Oral. 2003;8:383.
47. Fraser J. The management of oral conditions. Practitioner. 2004;248:330,333-336.
48. Murray B, Biagioni PA, Lamey PJ. The efficacy of amlexanox OraDisc on the prevention of recurrent minor aphthous ulceration. J Oral Pathol Med. 2006;35:117-122.
49. Fischman SL. Oral ulcerations. Semin Dermatol. 1994;13:74-77.
50. Gonzalez-Moles MA, Ruiz-Avila I, Rodriguez-Archilla A, et al. Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:688-692.
51. Savage NW, McCullough MJ. Topical corticosteroids in dental practice. Aust Dent J. 2005;50.
52. Murray B, McGuinness N, Biagioni P, Hyland P, Lamey PJ. A comparative study of the efficacy of aphtheal in the management of recurrent minor aphthous ulceration. J Oral Pathol Med. 2005;34:413-419.
53. Femiano F, Gombos F, Scully C. Recurrent aphthous stomatitis unresponsive to topical corticosteroids: a study of the comparative therapeutic effects of systemic prednisone and systemic sulodexide. Int J Dermatol. 2003;42:394-397.
54. Nolan A, Baillie C, Badminton J, Rudralingham M, Seymour RA. The efficacy of topical hyaluronic acid in the management of recurrent aphthous ulceration. J Oral Pathol Med. 2006;35:461-465